publications

  1. Cerulli Irelli, E et al.(2026)Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy. JAMA Neurol :.
  2. Sartori, G et al.(2026)Hypercapnia at admission, regardless of acidosis, may worsen the outcome of hospitalised patients with chronic obstructive pulmonary disease exacerbations. Intern Emerg Med :.
  3. Torres-Rodríguez, H et al.(2026)Phylogenomic and phenotypic profiling of carbapenem-resistant Pseudomonas aeruginosa clinical isolates reveals lineage-specific resistance mechanisms and adaptive responses. Microb Genom 12 (2):.
  4. Jiménez-Sánchez, IM et al.(2026)Reply. J Allergy Clin Immunol :.
  5. Wronski, N et al.(2026)RIPK4 function interferes with melanoma cell adhesion and metastasis. Mol Oncol :.
  6. Meunier, L et al.(2026)Plasma exchange as potential treatment of severe immune checkpoint inhibitor-induced hepatitis. JHEP Rep 8 (3):101684.
  7. Porcar, CA, Llorca Bofí, V, Mur Lain, M, Irigoyen Otiñano, M, López Castroman, J(2025)Mental health disparities between Spanish and foreign prison inmates: reasons for referral from prison to a specific unit in a general hospital. Rev Esp Sanid Penit 27 (3):102-112.
  8. Carneiro, G, Ferreira, I, Reigota, C(2026)Unilateral Tongue and Lip Edema: A Rare Presentation of Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema. Cureus 18 (1):e101033.
  9. Furtado, V et al.(2026)Assessing the User Experience of an LLM-Based Conversational Assistant in Diabetes Mellitus Care. J Healthc Inform Res 10 (1):116-153.
  10. Peretti, S et al.(2026)Age and onset timing of Raynaud's phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR). Ther Adv Musculoskelet Dis 18 :1759720X251410243.
  11. da Rocha, MJ et al.(2026)1‑(Phenylselanyl)-2‑(p‑tolyl)indolizine Mitigates Lipopolysaccharide (LPS)-Induced Depressive-Like Behavior by Modulating Oxidative Stress and Inflammatory Markers. ACS Omega 11 (4):6578-6590.
  12. Frescura, LM, Lourega, RV, da Silva, NW, da Rosa, MB(2026)Physical and Chemical Characterization, Adsorption Kinetics, Thermodynamic Analysis, and the Mechanism Involved in the Removal of Methylene Blue Dye by a Biosorbent from Pecan Nutshells. ACS Omega 11 (4):6707-6717.
  13. NEXT Collaboration(2026)The NEXT-100 Detector. Eur Phys J C Part Fields 86 (2):114.
  14. Ramos, F et al.(2026)Multifocal Osteoarticular Infection by Methicillin-Sensitive Staphylococcus aureus in the Neonatal Period: A Diagnostic Challenge. Cureus 18 (2):e103123.
  15. Abrantes, M, Clemente, T(2026)Letter: Fluoxetine for Behavioral Problems in an 8-Year-Old with Mucopolysaccharidosis IIIA. J Child Adolesc Psychopharmacol :10445463261422176.
  16. van der Veere, PJ et al.(2026)Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assays. Alzheimers Dement 22 (2):e71192.
  17. Nyssen, OP et al.(2026)Long-Term Effect of Macrolides on Helicobacter pylori Eradication: Data From the European Registry on Helicobacter pylori Management (Hp-EuReg). Helicobacter 31 (1):e70107.
  18. Riegler, C et al.(2026)Emergent Carotid Stenting During Endovascular Therapy for Isolated Cervical Internal Carotid Artery Occlusion. J Stroke 28 (1):160-171.
  19. Schiphorst, AT et al.(2026)Does the Benefit of Thrombectomy in Large Strokes Depend on Perfusion-Diffusion Mismatch? A Large Stroke Therapy Evaluation Trial Post Hoc Analysis. J Stroke 28 (1):115-125.
  20. Turpo-Peqqueña, AG et al.(2026)Angiographic outcomes after indirect revascularization in pediatric Moyamoya disease: a systematic review and Meta-analysis. Neurosurg Rev 49 (1):211.
Search PubMed